Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Coenzyme II

    • Product Name Coenzyme II
    • Alias NADP
    • Einecs 242-555-3
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    196256

    name Coenzyme II
    synonyms Nicotinamide Adenine Dinucleotide Phosphate, NADP+
    molecular_formula C21H28N7O17P3
    molecular_weight 743.4 g/mol
    appearance White to off-white powder
    solubility Soluble in water
    storage_temperature 2-8°C
    purity ≥95% (HPLC)
    CAS_number 53-59-8
    function Cofactor in redox reactions
    application Biochemical research, enzyme assays
    stability Stable under recommended storage conditions
    pH_range 6.5-8.5
    sensitivity Sensitive to light and heat
    source Synthetic or extracted from biological materials

    As an accredited Coenzyme II factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing The packaging for Coenzyme II contains 25 grams in a sealed amber glass bottle, labeled with product details and safety information.
    Shipping Coenzyme II should be shipped in a tightly sealed container under dry, cool conditions, protected from light and moisture to prevent degradation. It is typically classified as a non-hazardous chemical, but standard laboratory chemical shipping regulations apply. Ensure all regulatory documentation accompanies the shipment for safe and compliant transport.
    Storage Coenzyme II should be stored in a tightly sealed container, protected from light and moisture, at 2–8°C (refrigerated conditions) unless otherwise specified by the manufacturer. Avoid repeated freeze-thaw cycles to maintain stability. Handle under a nitrogen or inert atmosphere if instructed, and clearly label the storage container. Follow all institutional safety and chemical handling guidelines.
    Application of Coenzyme II

    Applications of Coenzyme II in Industrial Manufacturing

    As a direct producer of Coenzyme II, we supply a critical biochemical intermediate for various industrial manufacturing workflows. The following scenarios detail real-world downstream applications, presenting distinctive regulatory, technical, and end-product aspects for each sector.

    1. Pharmaceutical API Synthesis

    Pharmaceutical manufacturers incorporate Coenzyme II in multi-step synthesis of therapeutic agents, particularly where redox reaction control is vital. This raw material serves a key catalytic and electron transfer function in enzymatic and chemo-enzymatic steps, directly influencing the purity and reproducibility of active pharmaceutical ingredients targeting cardiovascular, metabolic, and neurological disease drug products. Process engineers carefully tune input ratios to match specific enzyme requirements, meeting stringent impurity and contaminant benchmarks enforced by international pharmacopoeias.

    Industry compliance standards

    • ICH Q7 (Good Manufacturing Practice for Active Pharmaceutical Ingredients)
    • Ph. Eur., USP, JP pharmacopoeial monographs (as relevant to API intermediates)
    • EU GMP Annex 1 for sterile production (where applicable)
    • FDA 21 CFR Part 210/211 for U.S. API manufacturing

    Typical usage ratio

    • 0.05–2.5 mol% relative to substrate per batch, adjusted based on redox cycle requirements and reaction scale

    Downstream process integration

    • Dosed into enzymatic reactors or chemo-enzymatic cascade columns after initial substrate loading, prior to main catalytic turnover step
    • Real-time adjustment possible through in-line redox monitoring
    • Final purification steps include chromatographic removal of unused or degraded coenzyme

    Final product types

    • Small molecule pharmaceuticals (e.g., statins, antidiabetics)
    • Biopharmaceutical intermediates
    • Prodrug precursor APIs

    2. Nutraceutical Production

    Companies manufacturing dietary supplements use Coenzyme II as a processing aid or active component in the preparation of fortified tablets, capsules, and functional beverages. Its controlled addition supports specific redox-dependent bio-conversion of precursors to bioavailable vitamin or amino acid forms, ensuring end-consumer formulations meet established health claims. Input amounts vary by batch size and local fortification guidelines, and traceability is required throughout blending and tableting operations.

    Industry compliance standards

    • ISO 22000:2018 Food Safety Management for production sites
    • EU Regulation No 2015/2283 (Novel Foods)
    • FDA 21 CFR Part 111 (Current Good Manufacturing Practice in Manufacturing, Packaging, Labeling, or Holding Operations for Dietary Supplements)
    • China GB 14880 for Food Additive Use

    Typical usage ratio

    • 5–50 mg/kg, determined by fortification requirements and functional additive policy in different jurisdictions

    Downstream process integration

    • Blended with vitamin and mineral premixes following primary extraction or synthesis step
    • Addition occurs prior to granulation and tableting or homogenization for liquid products
    • Final QA release after finished dosage analysis and shelf-life trials

    Final product types

    • Multivitamin tablets/capsules
    • Functional nutritional drinks
    • Amino acid enhanced supplements
    • Sports nutrition blends

    3. Industrial Biocatalysis for Fine Chemicals

    Chemical manufacturers integrate Coenzyme II into large-scale biocatalytic processes for producing fine chemicals, chiral compounds, and active intermediates. It acts as an essential cofactor with dehydrogenase and oxidoreductase biocatalysts, delivering high stereochemical control in asymmetric reductions or oxidations. Technical teams design input amounts based on substrate charge, enzyme turnover frequency, and process time. Process integration at the reactor stage is critical for maintaining economic conversion yields and fast downstream product isolation.

    Industry compliance standards

    • ISO 9001:2015 Quality Management Systems
    • REACH (EC No. 1907/2006) Registration for chemical manufacturing in Europe
    • Responsible Care® Management Systems for chemical safety
    • Local Environmental Discharge Regulations

    Typical usage ratio

    • 0.01–1.0 mol% relative to substrate, with optimization per turnover frequency and batch/continuous flow operation

    Downstream process integration

    • Metered into biocatalytic reactors at start-up or via controlled feed during reaction scale-up
    • Monitored with on-line sensors to maintain defined redox potential
    • Purified out or recycled in product isolation and solvent recovery section

    Final product types

    • Enantiopure alcohols/ketones
    • Specialty aldehydes/acids
    • Key API intermediates for custom synthesis

    4. Diagnostic Reagent Manufacturing

    Producers of diagnostic kits and enzyme assay systems rely on Coenzyme II for preparing in vitro and point-of-care test reagents. Used in enzyme-linked assays and colorimetric biosensor production, it enables precise signal generation in the detection of target metabolites. Teams fine-tune the inclusion rate to ensure signal linearity, background noise minimization, and thermal/storage stability of diagnostic formats. Full lot traceability is enforced for compliance and technical support during clinical trial supply and commercial runs.

    Industry compliance standards

    • ISO 13485:2016 Medical Device Quality Management System
    • IVDR (EU Regulation 2017/746) for in vitro diagnostic medical devices
    • FDA 21 CFR Part 820 for U.S. device and reagent manufacturing
    • Clinical Laboratory Standards Institute (CLSI) guidelines for diagnostics

    Typical usage ratio

    • 2–20 µg/test well or 0.01–0.1% (w/w) in liquid enzyme reagent preparations, optimized for each assay protocol

    Downstream process integration

    • Added into buffered enzyme blend during liquid filling or lyophilization stages
    • Packaged in single-use vials or blister compartments as part of complete kit assembly
    • QC release after enzymatic activity and shelf-stability confirmation

    Final product types

    • Blood glucose test strips
    • Clinical chemistry reagent kits
    • POCT (point-of-care testing) cassettes
    • Automated analyzer enzyme panels

    5. Fermentation Co-Factor Supplementation

    Industrial biotech fermentation plants, especially in amino acid and vitamin bulk production, supplement cultures with Coenzyme II to enhance growth rates and productivity in select microbial strains with engineered redox pathways. Operators adjust dosing schedules in line with fermentation kinetics and oxygen uptake rate, focusing on maximizing yield while maintaining downstream purity for food or pharma-grade output. This assistance occurs through sterile, calibrated pumps, usually in fed-batch or continuous stirred tank reactors.

    Industry compliance standards

    • FSSC 22000 for food-grade fermentation facilities
    • EU Regulation (EC) No. 183/2005 for feed and food additives
    • Relevant local environmental emission standards for byproduct handling
    • ISO/TS 22002-1:2009 Prerequisite Programmes on Food Safety

    Typical usage ratio

    • 10–150 mg/L fermentation broth, adjusted by strain performance and fermentation scalability testing

    Downstream process integration

    • Injected via sterile stock solution into bioreactors at lag or log growth phase
    • Sampling for cofactor concentration and microbial productivity throughout run
    • Final downstream separation removes excess coenzyme by ultrafiltration or adsorption resins

    Final product types

    • Fermentation-derived amino acids (e.g., L-glutamate, L-lysine)
    • Industrial-scale B-vitamin solutions
    • Feed and food additive concentrates

    6. Cosmetic Ingredient Preparation

    Personal care raw material suppliers use Coenzyme II in controlled amounts for stabilizing antioxidant and enzyme complexes included in high-value skincare and cosmetic serums. Its addition at the compounding phase enhances the activity profile of redox-sensitive ingredients, with suppliers validating efficacy by accelerated aging and compatibility testing. GMP batch records document every handling and mixing step to match non-pharmaceutical regulatory controls in this industry.

    Industry compliance standards

    • ISO 22716:2007 Cosmetics — Good Manufacturing Practices
    • EU Cosmetics Regulation (EC) No. 1223/2009
    • US FDA Voluntary Cosmetic Registration Program (VCRP)
    • China Cosmetic Ingredient Safety Technical Specifications 2021

    Typical usage ratio

    • 0.01–0.2% (w/w), optimized for compatibility with antioxidants, vitamins, and sensitive enzyme components

    Downstream process integration

    • Dispersed in aqueous or hydroalcoholic solution prior to final mixing of active concentrates
    • Integrated in the formulation under low-shear, temperature-controlled conditions to avoid degradation
    • QA sampling for stability and batch-to-batch color/odor control

    Final product types

    • Facial anti-aging serums
    • Brightening creams
    • Specialized enzyme or antioxidant boosters
    Free Quote

    Competitive Coenzyme II prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Coenzyme II: Real-World Innovation in Biocatalysis

    Introduction

    Coenzyme II stands as one of our most reliable and well-characterized cofactors, supporting a range of biochemical and industrial applications. Over the years, we've invested countless hours and resources optimizing our Coenzyme II model for high stability, purity, and lot-to-lot consistency. From fermentation all the way to downstream purification and final packaging, we handle every stage in-house to guarantee that what leaves our facility can keep up with the demands of high-volume processing environments.

    Clear Model and Exacting Standards

    We manufacture Coenzyme II under the strictest quality controls, ensuring that every kilogram adheres to the tested and published structural and purity standards, such as at least 98% HPLC purity and low residual moisture. Our current model, which code scientists refer to as CX-II-120, delivers tight control over variables that can confound batch-to-batch performance. Such precision plays a critical role when clients scale up from lab-scale trials to thousands of liters per year in continuous reactors.

    We settle for nothing less than verified physical parameters. CX-II-120 typically comes as a light-yellow, crystalline powder, stable at ambient temperatures when stored in dry, dark conditions. Water solubility reaches over 100 mg/mL, which helps formulators rapidly dissolve the product into aqueous mixtures and eliminates the headaches that can come with inconsistent cofactor concentrations.

    Why Consistency Matters

    Over two decades of direct manufacturing experience have shown us: the smallest batch-to-batch drift can undermine entire production runs. Many users rely on our Coenzyme II for high-throughput biotransformations, diagnostic kit assembly, or even sophisticated pharmaceutical syntheses that tolerate no “fudge factor.” Whether it’s the demand for purity or the need for a razor-thin melting point range, we run each lot through an exhaustive set of analytics—HPLC, NMR, TLC, moisture analysis, and finally, an activity assay with model dehydrogenase enzymes. If it doesn’t meet our internal spec, we do not ship it.

    Working close with clients who operate under cGMP and ISO 9001 systems has taught us that any impurity or inconsistency multiplies downstream risks. One missed variable can cause lot rejection, failed validation, or worse, a hidden impurity that skews results. We respond by over-specifying our analytical releases, not just reporting purity but also giving data on key contaminants and degradation fragments. This information helps our users tighten their own QA/QC pipelines and creates a true partnership—rather than just a supplier-customer transaction.

    Manufacturing in Our Own Facility

    Many products that pass through the market change hands several times before reaching the end user. We oversee our Coenzyme II batches from raw material reception to final shipment. This means ultimate traceability. Our technical support staff know every instrument setting and purification trick because they designed those methods based on real, long-term feedback from client sites. Over the years, we’ve reengineered columns, changed lyophilization cycles, and re-written entire SOPs to eliminate points of failure that surfaced only after enough real-world use.

    Running our own steam generation and maintaining our reactors reduces variability from seasonal temperature swings. We adapted our process to avoid chloride-based solvents, dropping the risk of residual ion contaminants that can throw off downstream catalysis. It also means we never have to scramble for alternate sourcing when global supply chains hiccup, so users see no surprises mid-process.

    Usage: More Than Just A Reagent

    Coenzyme II proves useful in dehydrogenase-based catalysis, diagnostics, amperometric biosensors, and several bulk chemical synthesis steps. Most users come to us first for oxidation-reduction reactions, where the cofactor shuttles reducing equivalents in tightly regulated enzyme pockets. Because some alternative sources struggle to remove byproduct nucleotides, users swapping over to our batches often see sharper peaks in HPLC and less trouble downstream during purification.

    Another growing application comes from the diagnostics industry. Single-use reagent kits now rely on such specialty materials that every contaminant, especially those with overlapping absorption spectra, can cause a misread. We’ve spent time working alongside diagnostic manufacturers to minimize UV-absorbing contaminants and ensure compatibility with colorimetric or electrochemical systems. This, in turn, boosts user-to-user reproducibility.

    For researchers working on enzyme evolution, a pure, properly-structured cofactor keeps mutation screens honest. Any drift in the redox carrier pools can mask or exaggerate library effects and undermine months of hard labor. Our Coenzyme II stays at the background, quietly doing its job, letting the real science unfold.

    Key Differences: Not All Products Are Made Equal

    People often ask what makes one coenzyme product better than the rest. The answer lies in lived experience with thousands of production cycles. We reject the thought that “coenzyme” means just one interchangeable chemical. Cheap knockoffs may focus solely on basic purity, overlooking trace formaldehyde or lower-energy fragments that sabotage kinetics or act as unwanted inhibitors.

    In one notable case, a client saw 13% lower enzyme turnover when using a competitor’s “pure” coenzyme. Through close collaboration, we traced the issue back to a trace degradation product acting as a competitive inhibitor. After switching to our CX-II-120 model, their reaction efficiency recovered. Stories like these come up more than anyone would like to admit, and they reinforce our commitment to unyielding specification.

    Packaging varies as well. We seal every lot in moisture-proof, light-blocking material, with container inert atmospheres for bulk users. This care keeps the cofactor’s structure protected throughout even the roughest transportation chain. Others sometimes use clear bags or fail to evacuate headspace—quick mistakes that force otherwise robust material into rapid degradation under lab lights.

    Stability Engineering: What We Learned From Our Own Failures

    Years ago, we lost an entire pallet to slight over-drying. The product, technically in-spec, crumbled to fine dust and led to dosing errors at a user facility. That event triggered a complete overhaul in drying and caking management. Now, we monitor the physical texture at each checkpoint, using both automated sieving and simple, hands-on product checks.

    During a feverish summer, we also discovered trace instability in one humid batch shipment. We introduced electronic humidity tracking at every warehouse node and started shipping with real-time loggers. Any deviation triggers a customer alert, and product recall if necessary. To this day, those monitors give us valuable feedback and sometimes even predict HVAC maintenance before it becomes an issue.

    Feedback cycles from real users drive most of our upgrades. Pharmaceutical partners in Southeast Asia alerted us to tropical heat issues, so we co-invested in insulated shipping and adaptive climate packaging. One user by the Black Sea requested smaller pack sizes to cut down on open-air exposure—our line now offers up to five variants from microtube vials to 10kg drums, each specially sealed. These concrete changes only became possible because we stayed closely tuned in to how the product travels and behaves in actual, not just optimal, conditions.

    Supporting Science with Transparency

    We believe the only way to build lasting trust is through direct, honest communication. For every batch, we release a full certificate with raw analytic data. Clients often want to dig into those files, verify retention times, or check for hidden peaks. Our teams gladly open our notebooks and walk users through key results, not just summary numbers. This transparency gives confidence to even the most demanding customers, many of whom need Coenzyme II for regulated processes or for inclusion in FDA or EMA dossier filings.

    Our technical staff have clocked thousands of hours troubleshooting with partners, both over the phone and on site. We know which storage protocols work and which are wishful thinking. We help users root out source problems, document failures, and validate every aspect of their own procurement chain.

    Ethics and Sustainability

    Our industry, like any industrial chemistry, faces tough questions about sustainability and ethical practices. We source all raw materials from vetted suppliers, most of whom are local whenever possible, reducing global supply chain risks and environmental footprint. We process waste in accordance with local and international environmental standards and aim every year to cut solvent consumption through process optimization.

    We support in-house recycling programs and have expanded our in-lab energy recovery by 14% over the last five years. Chemicals should do their job without causing more trouble for the planet or the people working with them.

    As environmental regulations tighten, we continue to collaborate openly with authorities and new partners. We participate in regular safety audits. That accountability trickles down—from warehouse workers through R&D to the hands of end users handling our product with confidence.

    Responding to Industry Trends

    Recent growth in the synthetic biology field has pushed Coenzyme II’s performance envelope. More users now require multistep, enzymatic processes that can run for days or weeks without cofactor degradation. Our R&D team responds by experimenting with alternate crystalline forms and stabilization agents, collaborating with academic labs when data falls outside what our internal projects can capture. Every improvement, large or small, filters back through our main production lines only after it passes months of stress testing under real-world conditions.

    We continue to invest in new analytics and trace impurity detection, even when competitors claim “good enough.” That hunger for improvement keeps our customers ahead of regulatory changes and enables them to support markets we haven’t even thought of yet.

    We work with custom and proprietary applications as well. Requests for special labeling, tamper-evidence, or custom formulation get managed by the people who understand why the changes matter—not just as an order, but as a collaborative technical challenge. Those investments cement strong partnerships and often spark new innovations for the entire field.

    Facing Challenges—Openly

    Challenges always appear, whether in the form of sudden raw materials price swings, pandemic disruptions, or global logistics headaches. More than once, we’ve had to overhaul entire sourcing channels due to geo-political events. Every solution circles back to better communication between our office, the line operators, and customer QA teams on the other side of the world.

    We also believe in acknowledging our own mistakes and learning fast. Supply interruptions, rare as they are, push us to keep bigger reserves, qualify back-up suppliers, and maintain open status updates for clients. Most importantly, we foster a culture where everyone—from line technician to chief chemist—feels encouraged to speak up about potential issues without fear of blame. This unity of purpose keeps everything running even when external factors pile up.

    Continuous Improvement

    Any manufacturer who stops upgrading falls behind. In our facility, we treat each process tweak as another chance to improve product quality or make life easier for users. Sometimes it’s as dramatic as a new chromatography system. Other times, it’s as simple as a stronger adhesive on the product label.

    Some upgrades never see the outside world, but most show up in smoother dispensing, steadier shelf lives, and clearer documentation. Our feedback loops reward those who notice small flaws, not just heroic overhauls. Users shouldn’t have to fight their materials.

    We pay equal attention to packaging and the “usability” factors that shorten lab time and prevent waste. Everyone from process chemists to logistics managers contributes ideas. After a client reported difficulty opening a previous vial design, we switched to a grip-friendly cap within three months. Our users drive these improvements by sharing what works and what causes headaches.

    Pushing the Limits of Reliability

    Reliability means more than specs. It means knowing every lot has predictable behavior, no matter the region or the size of the buy. We regularly test retained samples—sometimes years after initial production—to ensure nothing has crept out of spec. That long-term tracking gives users confidence that historic validation work stays relevant batch after batch.

    Whenever possible, we publish aggregate user data, de-identified and compliant with privacy rules. This ongoing data review has caught potential formulation or storage quirks before they ballooned into field-wide problems.

    Direct Support for User Innovation

    We treat customer R&D projects as extensions of our own innovation pipeline. Every time a client rigs up a new process or targets a harder substrate, we want to hear about it. Lessons from those frontier projects feed back into our ongoing optimization loop—sometimes steering us toward improvements we never would have found in our own labs.

    Consultations don't end with delivery. We field all sorts of technical requests—from verifying obscure UV absorption ranges to flagging possible incompatibilities with rare solvents or stabilizers. In some cases, our technical team ships alternate lots for fast, side-by-side trials, saving the end user from weeks of down time and cost.

    Our willingness to pitch in, share source data, and jointly troubleshoot complex processes keeps our clients at the vanguard of their fields. Many users refer us new projects not for our name, but because our materials behave as expected and our staff pick up the phone, document what happened, and follow through until the problem is solved.

    Looking to The Future

    We expect regulations to tighten, user requirements to evolve, and global chemical supply cycles to remain unpredictable. Our facility, our people, and our product will keep adapting. Current pilot projects focus on further impurity reduction, smarter packaging, and digital traceability. All of this emerges not from market trends, but directly from the feedback loop we maintain with the users and production hands who touch our product every day.

    Coenzyme II isn't just a commercial reagent on a spreadsheet—it’s the outcome of hundreds of small manufacturing, ethical, technical, and logistical choices, driven by lived experience and a commitment to putting better materials in the hands of scientists and engineers.